Hospitals in 2021 get a one.6% maximize for inpatient care paid by Medicare less than a proposed rule unveiled by the Centers for Medicare and Medicaid Solutions.
CMS is also proposing in the inpatient possible payment program rule to have a separate new hospital payment classification for Chimeric Antigen Receptor (Car) T-cell remedy.
Car-T is a gene remedy that works by using a patient’s individual genetically modified immune cells to treat people today with sure sorts of most cancers, alternatively of supplemental chemotherapy or other sorts of remedy paid for less than the inpatient possible payment program.
Presently, Car-T hospital scenarios are paid at the exact charge as bone marrow transplants and qualify for supplemental payments by way of the short-term new know-how insert-on payment for higher-cost scenarios which is set to expire this yr.
In addition, CMS is relocating forward with its selling price transparency rule demanding hospitals to